REG - Cel AI PLC - Board change

CEL AIAnnouncement

30/04/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240430:nRSd0802Ma&default-theme=true

RNS Number : 0802M  Cel AI PLC  30 April 2024

30 April 2024

 

This announcement contains information which, prior to its disclosure, was
inside information as stipulated under Regulation 11 of the Market Abuse
(Amendment) (EU Exit) Regulations 2019/310 (as amended). Upon the publication
of this announcement via a Regulatory Information Service, this inside
information is now considered to be in the public domain.

 

CEL AI plc

 

("Cel AI" or the "Company")

 

Board change

 

Cel AI (LSE: CLAI), a company specialising in cutting-edge artificial
intelligence (AI) to deliver tailored beauty advice and product
recommendations as well as next-generation skincare and wellness products,
announces that the Company and Gill Whitty Collins have agreed that Gill will
cease to be a non-executive director of the Company with effect from 30 April
2024, being the end of her fixed term engagement with the Company.

 

The Board would like to take this opportunity to thank Gill Whitty Collins for
her contribution to the Company and wish her well for the future.

 

For further information please contact:

 Cellular Goods
 Michael Edwards                          via FSCF +44 7572 873 300

 Director
 First Sentinel Corporate Finance (FSCF)
 Investor Relations

 Rebecca Noonan                           +44 7572 873 300

 ir@getcel.ai (mailto:ir@getcel.ai)

 Media Relations

 Rebecca Noonan                           +44 7572 873 300

 media@getcel.ai

 Corporate Broker & Advisor

 Brian Stockbridge                        +44 7858 888 007
 Novum Securities
 Corporate Broker

 Colin Rowbury

 Jon Belliss                              +44 207 399 9427

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAQKPBNBBKDOQB